Equipalazone
Active substance
ATC code
Species
Horses and ponies (non-food producing).
Indications
Indicated in the treatment of musculoskeletal disorders in horses and ponies where the anti-inflammatory and analgesic properties of phenylbutazone can offer relief, for example, in lameness associated with osteoarthritic conditions, acute and chronic laminitis, bursitis and carpitis.
Dose to be administered and administration route
Oral use.
Each marked division (2 turns of the ring) is equivalent to one unit dose (i.e. 1 g phenylbutazone).
Horses 450 kg (1000 lb): 2 unit doses twice on day one (equivalent to 8.8 mg/kg/day), 1 unit dose twice daily for four days (i.e. 4.4 mg/kg/day), followed by 1 unit dose daily or on alternate days (i.e. 2.2 mg/kg/day), sufficient to keep the horse comfortable.
Ponies 225 kg (500 lb): 1 unit dose (i.e. 4.4 mg/kg) on alternate days.
Remove cap from nozzle. Turn ring to required dosage. Express dose as near to the back of the tongue as possible. Replace cap after use. Store in a cool place. Discontinue treatment if no response is evident after four to five days.
Avoid the introduction of contamination during use.
Adverse reactions
Horses and ponies (non-food producing):
Non-steroidal anti-inflammatory drugs can cause inhibition of phagocytosis and hence in the treatment of inflammatory conditions associated with bacterial infections, appropriate concurrent antimicrobial therapy should be instigated.
Reporting adverse events is important. It allows continuous safety monitoring of a veterinary medicinal product. Reports should be sent, preferably via a veterinarian, to either the marketing authorisation holder or its local representative or the national competent authority via the national reporting system. See the package leaflet for respective contact details.
Dispensing
POM-V - Prescription Only Medicine – Veterinarian
PRICE | Only for registered vets. Create a free profile to access all features.. Login |
---|---|
Art. Nr. | 10434/4006 |
EAN | 5701170421965 |